奥罗拉B通过稳定c-Myc促进胆管癌的进展
Ke Liu1, Xuxuan Zhou2, Fei Huang1
1College of Pharmacy, Jinan University, Guangzhou, China.
Animal models and experimental medicine
|January 22, 2024
概括
在胆管癌 (CCA) 中,Aurora B 激酶被上调,通过稳定c-Myc.促进瘤生长. 抑制Aurora B为CCA提供了新的治疗策略,并提高了化疗的有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 胆管癌 (CCA) 预后不好,目标治疗有限.
- 极光B激酶是一种线粒调节剂,涉及到各种癌症,但其在CCA中的作用尚不清楚.
研究的目的:
- 调查 Aurora B 在胆管癌进展中的作用和治疗潜力.
- 探索Aurora B作为CCA的新型治疗点.
主要方法:
- 在人类CCA组织和小鼠模型中评估了Aurora B表达.
- 在CCA细胞中利用功能丧失模型 (siRNA,HDO) 和Aurora B抑制剂 (AZD1152).
- 在皮下和正管异种移植模型中评估治疗疗效.
主要成果:
- 在CCA组织中,Aurora B显著上调,与生存率差相关.
- 光B抑制通过诱导G2/M停止来抑制CCA进展.
- 光B稳定c-Myc,促进CCA恶性病变;抑制减少了这种相互作用.
- 在CCA模型中,Aurora B抑制增强了gemcitabine的疗效.
结论:
- 极光B对CCA进展至关重要,主要是通过调节c-Myc稳定性.
- 极光B代表了对胆管癌的有前途的治疗点.
- 准Aurora B可以使CCA对化疗敏感,改善治疗结果.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


